• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人肺炎的病因、临床病程和转归:泰国一项回顾性和前瞻性队列研究。

Etiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand.

机构信息

1Faculty of Tropical Medicine, Mahidol University, Ratchathewi, Bangkok, Thailand.

2Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand.

出版信息

Am J Trop Med Hyg. 2021 May 3;104(6):2009-2016. doi: 10.4269/ajtmh.20-1393.

DOI:10.4269/ajtmh.20-1393
PMID:33939631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8176510/
Abstract

Pneumonia is a leading cause of hospitalization and death among elderly adults. We performed a retrospective and prospective observational study to describe the etiology, clinical course, and outcomes of pneumonia for patients 60 years and older in Thailand. We enrolled 490 patients; 440 patients were included in the retrospective study and 50 patients were included in the prospective study. The CURB-65 score and a modified SMART-COP score (SMART-CO score) were used to assess disease severity. The median patient age was 80 years (interquartile range, 70-87 years); 51.2% were men. Klebsiella pneumoniae (20.4%) and Pseudomonas aeruginosa (15.5%) were the most common causative agents of pneumonia. A significant minority (23%) of patients were admitted to the intensive care unit (ICU), and mortality among this subset of patients was 45%. Most patients (80.8%) survived and were discharged from the hospital. The median duration of hospitalization was 8 days (interquartile range, 4-16 days). In contrast, 17.6% of patients died while undergoing care and 30-day mortality was 14%. Factors significantly associated with mortality were advanced age (P = 0.004), male sex (P = 0.005), multiple bacterial infections (P = 0.007; relative risk [RR], 1.88; 95% confidence interval [CI], 1.19-2.79), infection with multi-drug-resistant/extended-spectrum B-lactamase-producing organisms (P < 0.001; RR, 2.82; 95% CI, 1.83-4.85), ICU admission (P < 0.001; RR, 1.8; 95% CI, 1.4-2.3), and complications of pneumonia (P < 0.001; RR, 2.5; 95% CI, 1.8-3.4). Patients with higher SMART-CO and CURB-65 scores had higher rates of ICU admission and higher 30-day mortality rates (P < 0.001). These results emphasize the importance of Gram-negative bacteria, particularly K. pneumoniae and P. aeruginosa, as major causes of pneumonia among the elderly in contrast to other reports, Streptococcus pneumoniae is a common cause of pneumonia among elderly individuals worldwide. The SMART-COP and CURB-65 scores were developed to assess pneumonia severity and predict mortality of young adults with pneumonia. Few studies have examined the appropriateness of these scores for elderly patients with multiple comorbidities. A limited number of studies have used modified versions of these scores among elderly individuals. We found that Gram-negative bacteria has a major role in the etiology of pneumonia among elderly individuals in Southeast Asia. A significant proportion of elderly individuals with low CURB-65 scores were admitted to the hospital, indicating that hospital admission may reflect fragility among elderly individuals with low CURB-65 scores. The modified SMART-COP score (SMART-CO score) sufficiently predicted intensive care unit admission and the need for intensive vasopressor or respiratory support. A SMART-CO score ≥ 7 accurately predicted 30-day mortality.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/8176510/bd6c7da0f97a/tpmd201393f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/8176510/65a860331b12/tpmd201393f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/8176510/bd6c7da0f97a/tpmd201393f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/8176510/65a860331b12/tpmd201393f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/8176510/bd6c7da0f97a/tpmd201393f2.jpg
摘要

肺炎是导致老年人住院和死亡的主要原因之一。我们进行了一项回顾性和前瞻性观察性研究,以描述泰国 60 岁及以上老年人肺炎的病因、临床过程和结局。我们共纳入了 490 名患者;440 名患者纳入回顾性研究,50 名患者纳入前瞻性研究。CURB-65 评分和改良 SMART-COP 评分(SMART-CO 评分)用于评估疾病严重程度。患者的中位年龄为 80 岁(四分位间距,70-87 岁);51.2%为男性。肺炎克雷伯菌(20.4%)和铜绿假单胞菌(15.5%)是肺炎最常见的病原体。少数(23%)患者入住重症监护病房(ICU),该亚组患者的死亡率为 45%。大多数患者(80.8%)存活并从医院出院。中位住院时间为 8 天(四分位间距,4-16 天)。相比之下,17.6%的患者在接受治疗时死亡,30 天死亡率为 14%。与死亡率显著相关的因素包括高龄(P = 0.004)、男性(P = 0.005)、多重细菌感染(P = 0.007;相对风险 [RR],1.88;95%置信区间 [CI],1.19-2.79)、感染多药耐药/产超广谱β-内酰胺酶的病原体(P < 0.001;RR,2.82;95%CI,1.83-4.85)、入住 ICU(P < 0.001;RR,1.8;95%CI,1.4-2.3)和肺炎并发症(P < 0.001;RR,2.5;95%CI,1.8-3.4)。SMART-CO 和 CURB-65 评分较高的患者 ICU 入住率和 30 天死亡率较高(P < 0.001)。这些结果强调了革兰氏阴性菌(尤其是肺炎克雷伯菌和铜绿假单胞菌)在东南亚老年人群中作为肺炎主要病原体的重要性,与其他报告不同,肺炎链球菌是全球老年人中常见的肺炎病原体。SMART-COP 和 CURB-65 评分用于评估肺炎的严重程度和预测肺炎年轻患者的死亡率。很少有研究检查这些评分在患有多种合并症的老年患者中的适用性。一些研究使用了这些评分的改良版本。我们发现,革兰氏阴性菌在东南亚老年人肺炎的病因学中起主要作用。相当一部分 CURB-65 评分较低的老年患者住院,这表明住院可能反映了 CURB-65 评分较低的老年患者的脆弱性。改良 SMART-COP 评分(SMART-CO 评分)足以预测入住 ICU 和需要强化血管加压或呼吸支持。SMART-CO 评分≥7 可准确预测 30 天死亡率。

相似文献

1
Etiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand.老年人肺炎的病因、临床病程和转归:泰国一项回顾性和前瞻性队列研究。
Am J Trop Med Hyg. 2021 May 3;104(6):2009-2016. doi: 10.4269/ajtmh.20-1393.
2
Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.住院社区获得性肺炎的预后因素:一项前瞻性观察队列的回顾性研究
BMC Pulm Med. 2017 May 2;17(1):78. doi: 10.1186/s12890-017-0424-4.
3
Performance of various pneumonia severity models for predicting adverse outcomes in elderly inpatients with community-acquired pneumonia.各种肺炎严重程度模型预测老年社区获得性肺炎住院患者不良结局的性能。
Clin Microbiol Infect. 2024 Nov;30(11):1426-1432. doi: 10.1016/j.cmi.2024.07.008. Epub 2024 Jul 14.
4
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.社区获得性肺炎的肺炎严重指数Ⅴ级患者:特征、结局及严重程度评分的价值
Chest. 2007 Aug;132(2):515-22. doi: 10.1378/chest.07-0306. Epub 2007 May 15.
5
Validity of SMART-COP score in prognosis and severity of community acquired pneumonia in the emergency department.SMART-COP 评分在急诊科社区获得性肺炎预后和严重程度评估中的有效性。
Am J Emerg Med. 2019 Aug;37(8):1450-1454. doi: 10.1016/j.ajem.2018.10.044. Epub 2018 Oct 21.
6
Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.肝硬化患者社区获得性肺炎:临床特征、结局及严重程度评分的实用性
Medicine (Baltimore). 2011 Mar;90(2):110-118. doi: 10.1097/MD.0b013e318210504c.
7
Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.成人社区获得性肺炎住院患者中“非典型病原体”的作用。
Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5.
8
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study.COVID-19 住院患者社区获得性肺炎严重程度评估工具:验证和临床适用性研究。
Clin Microbiol Infect. 2021 Jul;27(7):1037.e1-1037.e8. doi: 10.1016/j.cmi.2021.03.002. Epub 2021 Apr 2.
9
Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumonia.应用和比较评分指标预测医疗相关性肺炎患者的结局。
Crit Care. 2011;15(1):R32. doi: 10.1186/cc9979. Epub 2011 Jan 19.
10
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.社区获得性肺炎由多重耐药和非多重耐药铜绿假单胞菌引起。
Chest. 2016 Aug;150(2):415-25. doi: 10.1016/j.chest.2016.03.042. Epub 2016 Apr 7.

引用本文的文献

1
Viral non-SARS-CoV-2 etiology of community-acquired pneumonia (CAP) in Southeast Asia: a review and pooled analysis.东南亚社区获得性肺炎(CAP)的病毒非严重急性呼吸综合征冠状病毒2病因:综述与汇总分析
IJID Reg. 2025 May 17;15:100672. doi: 10.1016/j.ijregi.2025.100672. eCollection 2025 Jun.
2
Predictors of Poor Pneumonia Outcomes in Older Adults: A Multicentered Follow-Up Study.老年人肺炎不良预后的预测因素:一项多中心随访研究。
Health Sci Rep. 2025 Apr 18;8(4):e70666. doi: 10.1002/hsr2.70666. eCollection 2025 Apr.
3
Alterations in the prevalence and serotypes of Streptococcus pneumoniae in elderly patients with community-acquired pneumonia: a meta-analysis and systematic review.
老年社区获得性肺炎患者肺炎链球菌的患病率及血清型变化:一项荟萃分析与系统评价
Pneumonia (Nathan). 2025 Feb 25;17(1):5. doi: 10.1186/s41479-025-00156-0.
4
Vaccine Hesitancy Affecting Pneumococcal Vaccine Refusal in Older Adults with Morbidities.疫苗犹豫对患有慢性病的老年人群中肺炎球菌疫苗拒绝接种的影响。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241303568. doi: 10.1177/21501319241303568.
5
Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with , , and : A retrospective cohort study in Jakarta, Indonesia.与感染、和的重症肺炎患者抗生素耐药性及生存分析相关的因素:印度尼西亚雅加达的一项回顾性队列研究
SAGE Open Med. 2024 Aug 27;12:20503121241264097. doi: 10.1177/20503121241264097. eCollection 2024.
6
Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India.60 岁及以上因肺炎住院的患者的不良结局:印度一项前瞻性多中心医院为基础的研究。
PLoS One. 2024 May 2;19(5):e0297452. doi: 10.1371/journal.pone.0297452. eCollection 2024.
7
Pulmonary Diseases in Older Patients: Understanding and Addressing the Challenges.老年患者的肺部疾病:理解并应对挑战
Geriatrics (Basel). 2024 Mar 7;9(2):34. doi: 10.3390/geriatrics9020034.
8
Development and validation of a predictive model for 30-day mortality in patients with severe community-acquired pneumonia in intensive care units.重症监护病房中重症社区获得性肺炎患者30天死亡率预测模型的开发与验证
Front Med (Lausanne). 2024 Jan 8;10:1295423. doi: 10.3389/fmed.2023.1295423. eCollection 2023.
9
A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia.预测老年社区获得性肺炎患者中铜绿假单胞菌感染的评分。
BMC Infect Dis. 2023 Oct 19;23(1):700. doi: 10.1186/s12879-023-08688-w.
10
Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review.血浆白蛋白在预后指标中的作用解读:文献综述
J Clin Med. 2023 Sep 22;12(19):6132. doi: 10.3390/jcm12196132.